Inotrópicos

Dobutamina Si ( ) No ( )
Dopamina Si ( ) No ( )
Digoxina Si ( ) No ( )

Complicaciones

Insuficiencia cardiaca: Según clasificación de Killip Kimbal

I ( ) No signos de insuficiencia cardiaca
II ( ) insuficiencia cardiaca ligera – moderada
III ( ) Edema pulmonar agudo
IV ( ) shock cardiogénico

Angina Post-Infarto Si ( ) No ( ) Reinfarto si ( ) No ( )

Arritmias documentadas en la historia clínica

Fibrilación Auricular Si ( ) No ( )
Taquicardia Ventricular Si ( ) No ( )
Extrasistolia Ventricular Frecuentas ( )

Trastornos de la conducción documentados en la historia clínica

Bloqueo Aurículo-Ventricular de segundo grado Mobitz II. Si ( ) No ( )
Bloqueo Aurículo-Ventricular de tercer grado. Si ( ) No ( )

Estado al Egreso

Vivo ( )
Fallecido ( )

Referencias Bibliográficas

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-504.
2. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guía Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2007;60(10):1070.e1-e80.
3. Murga N, Barrás X, Barrios V, Pedreira M. Actualización en cardiología clínica. Rev Esp Cardiol. 2008;61 (Supl 1): 86-96.
4. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, KottkeTE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-98.
5. Rosamond W, Flegal K, Friday G. Heart disease and stroke statistcs- 2007 update: a report form the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-171.
6. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernández R, Gray A. European Cardiovascular Disease Statistics: 2005 edition. London: British Heart Fundation; 2005.
7. Leal J, Luengo- Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:107-13.
8. Velázquez M O. Morbilidad y mortalidad de la enfermedad isquémica del corazón y cerebrovascular en México. 2005. Arch Cardiol Mex. 2007; 77: 31-39.
9. Venezuela, Ministerios de Salud y Desarrollo Social. Dirección de Estadística. Caracas: MSDS; 2005.
10. Cuba, Ministerio de Salud Pública. Dirección Nacional de Estadística. Informe Anual Estadísticas Vitales. Ciudad de La Habana: MINSAP; 2006.
11. Bueno H. Síndrome Coronario Agudo: un concepto clínico de rápida evolución. Cardiovascular Risk Factors. 2003;12(6):335-337.
12. Bueno H. Síndromes coronarios agudos: entre la confusión y la claridad terminológica. Cardiología Práctica. 2002;11:1-3.
13. Braunwald E. ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2000; 36:970-1056.
14. Terol I, San Martin MA, García A y col. Síndrome Coronario Agudo: nuevo enfoque fisiopatológico. Cardiovascular Risk Factors. 2003;12(1):35-42.
15. Thompson PD, Buchner D, Pina IL. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Phisical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109-16.
16. Poirier P, Giles TD, Bray GA. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease form the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
17. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
18. Anderson JL, Adams CD, Antman EM, Bridges CR, Calif RM, Casey DE, et al. ACC/AHA 2007 Guidelines for the Management of Patients with Angina/Non –ST –Elevation Myocardial Infarction. JACC. 2007;50(7):e1-157.
19. Hamm C, Heeschen C, Falk E, Fox KAA. Acute coronary syndromes: pathophysiology, diagnosis and risk stratification. En: Camm AJ, Luescher TF, Serruys PW, editores. The ESC Textbook of Cardiovascular Medicine. Oxford: UK, Blackwell Publishing; 2006.p.333-66.
20. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83:361-6.
21. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-72.
22. Buffon A, Biasucci LM, Liazzo G, D´Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med. 2002;347:5-12.
23. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699-708.
24. Davies MJ, Tomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 1986;73:418-27.
25. Bugiardini R, Bairey Merz CN. Angina with normal coronary arteries: a changing philosophy. JAMA. 2005;293:477-84.
26. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105:546-9.
27. Skyschally A, Leineweber, Gres P, Haude M, Erbel R, Heusch G. Coronary microembolization. Basic Res Cardiol. 2006;101:373-83.
28. Alpert JS,Thygesen K, Antman EM, Bassand JP. Myocardial infarction redefined¬- a consensus document of The Joint European Society/American College of Cardiology Committee for redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-13.
29. Tofler GH, Muller JE. Triggering of acute cardiovascular disease and potential preventive strategies. Circulation. 2006;114:1863-72.
30. Goff DC, Seller DE, McGovern PG. Knowledge of heart attack symptoms in a population survey in the United States: the REACT Trial. Rapid Early Action for Coronary Treatment. Arch Intern Med. 1998;158:2329-38.
31. Abidov A, Rozanski A, Hachamovitich R. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med. 2005;353:1889-
32. Goff DC, Feldman HA, McGovern PG. Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT Trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. Am Heart J. 1999;138:1046-57.
33. Holmvang L, Clemmensen P, Lindahl B, Lagerqvist B, Venge P, Wagner G, et al. Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol. 2003;41:905-15.
34. Savonitto S, Ardissino D, Granger CB. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707-13.
35. Zaacks SM, Liebson PR, Calvin JE, Parrillo JE, Klein LW. Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol. 1999;33:107-18.
36. Menown IB, Mackenzei G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J. 2000;21:275-83.
37. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction JACC. 2000;36:959-69.
38. Albalá N, Ancillo P. El síndrome coronario agudo en su clasificación actual. Med Intensiva. 2006;30(2):74-6.
39. Mauri F, Gasparini M, Barbonaglia L. Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol. 1989;63:1291-5.
40. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave front phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration occlusion in dogs. Circulation. 1977;56:786-794.
41. Roger VL, Killian JM, Weston SA. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation. 2006;114:790-7.
42. Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522-523.
43. Moliterno DJ, Aguirre FV, Cannon CP. The Global unstable angina registry and treatment evaluation. Circulaton. 1996;94:I.
44. Mishell JM, Waters DD. Diagnóstico y tratamiento de los pacientes con Angina Inestable Aguda. En: O´Rourke RA, Fuster V, Alexander RW, Roberts R, King SB, Wellens HJ (eds): El Corazón. Hurst,10ma ed. New York: McGraw-Hill;2001:297-320.
45. White HD. Unstable Angina. In: Topol EJ (ed): Textbook of Cardiovascular Medicine, 3rd edition. Lippincott Williams and Wilkins; 2007:252-279.
46. Hyde TA, French JK, Wong CK, et al. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. Am J Cardiol. 1999;84:379-385.
47. Hamm C, Ravkilde J, Gerhar W. The prognosis value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.
48. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina Refractory to standard treatment trial. J Am Coll Cardiol. 2000;35:1535-42.
49. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro.brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary arteries disease: a Global Utilization of Strategies to open occluded arteries (GUSTO) - IV substudy. Circulation. 2003;108:275-81.
50. Mueller C, Laule-kilian K, Schindler C, Klima T, Frana B, Rodriguez D, et al. Cost-effectivenees of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med. 2006;106:1081-7.
51. Bueno H. Introducción: puntos claves en el manejo del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol Supl. 2005;5:1c-7c.